The recent findings of a huge study may erase some concerns about a pain reliever that has long been saddled with a worrisome reputation: celecoxib (Celebrex). While all nonsteroidal anti-inflammatory ...

Objectives We hypothesised that celecoxib, a COX-2 specific inhibitor, would be as effective as conventional NSAIDs and better than placebo in the treatment of ankle sprain. Methods Two separate ...

In addition, although not a prespecified endpoint, rofecoxib resulted in significantly greater improvement than celecoxib in scores for each of the WOMAC composite domains (pain, stiffness, and ...

An analysis of data from a randomized clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib, an anti-inflammatory drug, after surgery ...

Nearly a decade after reports first surfaced linking the prescription pain reliever celecoxib (Celebrex) to an increased risk of heart attack, and two years after the American Heart Association ...

The analysis showed that patients with positive blood tests for circulating tumor DNA (ctDNA) had worse outcomes in general, but those who were treated with celecoxib, a non-steroidal anti ...

We evaluated opioid-sparing effects and rehabilitative results after perioperative celecoxib administration for total knee arthroplasty. Methods: This was a prospective, randomized, observer-blind ...